Trial reportBMJ open2019
Effect of text messaging on depression in patients with coronary heart disease: a substudy analysis from the TEXT ME randomised controlled trial.
Trial report in BMJ open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.
- The Effects of mHealth Interventions on Quality of Life, Anxiety, and Depression in Patients With Coronary Heart Disease: Meta-Analysis of Randomized Controlled Trials.Journal of medical Internet research · 2024Pooled it
- Trial
- Digital Educational Strategies to Implement Evidence-Based Care for Atherosclerotic Cardiovascular Disease.Current atherosclerosis reports · 2026Review
- The HeartHealth Program: A Mixed Methods Study of a Community-Based Text Messaging Support Program for Patients With Cardiovascular Disease From 2020 to 2024.JMIR cardio · 2026Article
- Effect of theBMJ open · 2025Article
- Article
- Persuasive Systems Design Trends in Coronary Heart Disease Management: Scoping Review of Randomized Controlled Trials.JMIR cardio · 2024Article
- Secondary prevention in coronary artery disease: development and content validity of educational messages for mobile phones.Revista da Escola de Enfermagem da U S P · 2023Article
- Text Messages for Depression, Anxiety and Alcohol Abuse Therapy-Are Construction Guidelines Needed?International journal of environmental research and public health · 2022Article
- Efficacy of digital health interventions on depression and anxiety in patients with cardiac disease: a systematic review and meta-analysisEuropean heart journal. Digital health · 2022Review
- Smartphone Apps for Diabetes Medication Adherence: Systematic Review.JMIR diabetes · 2022Review
- Machine learning models for prediction of co-occurrence of diabetes and cardiovascular diseases: a retrospective cohort study.Journal of diabetes and metabolic disorders · 2022Article
- Factors Associated with Chronic Kidney Disease in Patients with Type 2 Diabetes in Bangladesh.International journal of environmental research and public health · 2021Article
- Cardiovascular diseases risk prediction in patients with diabetes: Posthoc analysis from a matched case-control study in Bangladesh.Journal of diabetes and metabolic disorders · 2021Article
- mHealth Interventions to Support Prescription Opioid Tapering in Patients With Chronic Pain: Qualitative Study of Patients' Perspectives.JMIR formative research · 2021Article
- Digital Interventions for Psychological Comorbidities in Chronic Diseases-A Systematic Review.Journal of personalized medicine · 2021Review
- Digital health approaches for cardiovascular diseases prevention and management: lessons from preliminary studies.mHealth · 2021Article
- Article
- The Use of Text Messaging to Improve Clinical Engagement for Individuals With Psychosis: Systematic Review.JMIR mental health · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 3 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveWe aimed to evaluate the effects on depression scores of a lifestyle-focused cardiac support programme delivered via mobile phone text messaging among patients with coronary heart disease (CHD).
designSubstudy and secondary analysis of a parallel-group, single-blind randomised controlled trial of patients with CHD.
settingA tertiary hospital in Sydney, Australia.
interventionThe Tobacco, Exercise and dieT MEssages programme comprised four text messages per week for 6 months that provided education, motivation and support on diet, physical activity, general cardiac education and smoking, if relevant. The programme did not have any specific mental health component. OUTCOMES: Depression scores at 6 months measured using the Patient Health Questionnaire-9 (PHQ-9). Treatment effect across subgroups was measured using log-binomial regression model for the binary outcome (depressed/not depressed, where depressed is any score of PHQ-9 ≥5) with treatment, subgroup and treatment by subgroup interaction as fixed effects.
resultsDepression scores at 6 months were lower in the intervention group compared with the control group, mean difference 1.9 (95% CI 1.5 to 2.4, p<0.0001). The frequency of mild or greater depressive symptoms (PHQ-9 scores≥5) at 6 months was 21/333 (6.3%) in the intervention group and 86/350 (24.6%) in the control group (relative risk (RR) 0.26, 95% CI 0.16 to 0.40, p<0.001). This proportional reduction in depressive symptoms was similar across groups defined by age, sex, education, body mass index, physical activity, current smoking, current drinking and history of depression, diabetes and hypertension. In particular, the rates of PHQ-9 ≥5 among people with a history of depression were 4/44 (9.1%) vs 29/62 (46.8%) in intervention vs control (RR 0.19, 95% CI 0.07 to 0.51, p<0.001), and were 17/289 (5.9%) vs 57/288 (19.8%) among others (RR 0.30, 95% CI 0.18 to 0.50, p<0.001).
conclusionsAmong people with CHD, a cardiac support programme delivered via mobile phone text messaging was associated with fewer symptoms of mild-to-moderate depression at 6 months in the treatment group compared with controls. TRIAL REGISTRATION NUMBER: ACTRN12611000161921.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.